Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Chunyan Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2392-3185; OpenAlex author ID A5026930533. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 5

  1. Human Pancreatic Cancer Organoids. Co-author DOI 10.1111/cpr.70210↗
  2. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy. Co-author DOI 10.1016/j.biomaterials.2024.122574↗
  3. Corrigendum to "PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer" [Gene 642 (2018… Last author DOI 10.1016/j.gene.2020.144401↗
  4. PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer. Last author DOI 10.1016/j.gene.2017.11.014↗
  5. Overexpression and biological function of MEF2D in human pancreatic cancer. Last author PMID 29218083↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiwang Song · 3 shared papers, 2017–2020 · strength 0.33
  2. Mengyao Chen · 1 shared paper, 2024 · strength 0.19
  3. Shuo Shi · 1 shared paper, 2024 · strength 0.19
  4. Xianming Kong · 1 shared paper, 2026 · strength 0.18
  5. Aina He · 1 shared paper, 2026 · strength 0.18
  6. Xiaoguang Wang · 1 shared paper, 2026 · strength 0.18
  7. Ting Han · 1 shared paper, 2026 · strength 0.18
  8. Zunqiang Zhou · 1 shared paper, 2026 · strength 0.18
  9. Dongxi Xiang · 1 shared paper, 2026 · strength 0.18
  10. Yong Gao · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.